California Granted Fate Therapeutics $15 Million for Lupus
The funding supports a Phase 2 trial of an off-the-shelf CAR T cell therapy for severe systemic lupus.
Live Poll
Should public institutions provide financial grants to private companies for pharmaceutical research and development?